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ABSTRACT
Introduction Palliative care is a clinically and cost‐
effective component of cancer services in sub- Saharan 
Africa (SSA). Despite the significant need for palliative 
cancer care in SSA, coverage remains inadequate. The 
exploration of digital health approaches could support 
increases in the quality and reach of palliative cancer care 
services in SSA. However, there is currently a lack of any 
theoretical underpinning or data to understand stakeholder 
drivers for digital health components in this context. This 
project addresses this gap through engaging with key 
stakeholders to determine data and information needs that 
could be supported through digital health interventions.
Methods and analysis This is a multicountry, cross- 
sectional, qualitative study conducted in Nigeria, Uganda 
and Zimbabwe. In- depth interviews will be conducted in 
patients with advanced cancer (n=20), caregivers (n=15), 
health professionals (n=20) and policy- makers (n=10) in 
each of the three participating countries. Data from a total 
of 195 interviews will transcribed verbatim and translated 
into English before being imported into NVivo software 
for deductive framework analysis. The analysis will seek 
to understand the acceptability and define mechanisms 
of patient- level data capture and usage via digital 
technologies.
Ethics and dissemination Ethics approvals have been 
obtained from the Institutional Review Boards of University 
of Leeds (Ref: MREC 18–032), Research Council of 
Zimbabwe (Ref: 03507), Medical Research Council of 
Zimbabwe (Ref: MRCZ/A/2421), Uganda Cancer Institute 
(Ref: 19–2018), Uganda National Council of Science and 
Technology (Ref: HS325ES) and College of Medicine 
University of Lagos (Ref: HREC/15/04/2015). The project 
seeks to determine optimal mechanisms for the design 
and development of subsequent digital health interventions 
to support development, access to, and delivery of 
palliative cancer care in SSA. Dissemination of these 
findings will occur through newsletters and press releases, 
conference presentations, peer- reviewed journals and 
social media.
Trial registration number ISRCTN15727711
InTRoduCTIon
Due to late- stage clinical presentation, limited 
funding and restricted access to curative ther-
apies, about 80% of cancers on the continent 
are incurable at the time of detection and 
diagnosis.1 In 2018, there were over 770 000 
new cancer cases and 514 000 cancer- related 
deaths across Eastern, Middle, Southern and 
Western Africa.2 These figures are projected 
to continue to rise (up to 1.28 million new 
cases and 970 000 deaths) by 2030, with 
subsequent international and regional 
Strengths and limitations of this study
 ► This study is the first to identify preferences of 
stakeholders involved in palliative cancer care pro-
vision in sub- Saharan Africa to inform digital health 
approaches.
 ► All aspects of the proposed study have been copro-
duced with experts in palliative care delivery and 
research in Nigeria, Uganda and Zimbabwe.
 ► This multicountry study will generate a logic model 
to target digital health approaches for palliative care 
that could have relevance across the sub- Saharan 
Africa region.
 ► This study restricts its focus to palliative cancer care 
so its relevance to other palliative conditions may 
be limited.
 ► The findings may not be reproducible beyond the 
three participating countries.
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political declarations constituting a new global non- 
communicable disease agenda.3 Increasing incidence is 
attributed to factors that include ageing, high residual 
burden of infectious agents (HIV/AIDS, human papil-
lomavirus, hepatitis B virus) and lifestyle factors in sub- 
Saharan Africa (SSA).4 Our analysis reveals that by 2060, 
an estimated 16 million people with cancer will die annu-
ally with serious health- related suffering, a 109% increase 
between 2016 and 2060, with the fastest rise occurring in 
low- income countries (400% increase).5
Palliative care (PC)—the prevention and relief of phys-
ical, emotional, social or spiritual suffering associated 
with any chronic or life- threatening illness, from the point 
of diagnosis—is a vital and fundamental component of 
the basic and essential services within universal health 
coverage (UHC).6 It is also a realistic response to support 
equitable, accessible and cost‐effective interventions for 
cancer care in SSA. Independent of cancer prevention 
and treatment efforts in the region, PC remains a critical 
and essential component of care, with proven effective-
ness and cost- effectiveness.7 8 There have been enormous 
strides made in the development of PC services in the SSA 
region,9 10 but there remains a need for significant expan-
sion of provision to meet demand. Current provision of 
PC services is limited to 24 of 48 countries, up from only 
five in 2004, with only less than 5% of people who need 
PC being able to access services in the region.10
A major challenge to developing palliative cancer care 
across the African region is the lack of local evidence 
to ensure practice is evidence- based and replicable and 
reflects the needs of the population served.6 Evidence 
to date has revealed that patients with advanced cancer 
in SSA have a high burden of physical and psycholog-
ical symptoms, would prefer to have full information 
and better communication around their needs and 
care options, experience spiritual distress, their family 
caregivers face compounded poverty and psychological 
distress.11–18 It is essential to create channels for gath-
ering patient- level data as an indicator of quality as well 
as to inform clinical practice and audit. Furthermore, 
understanding how emerging services are supporting 
patients with advanced cancer through assessing expe-
riences and outcomes is a priority for PC development 
in the region.19 This can be achieved through the use of 
validated, context- specific tools for measuring outcomes 
for PC patients and their caregivers in SSA.19 20 We have 
therefore developed a valid patient- reported outcome 
measure (PROM) for advanced disease in SSA to capture 
the core concerns of patients and families.21–23 Capturing 
these data can enable development and adaptation of 
services to ensure they can respond to the specific needs 
of patients with cancer.
This protocol describes a study to explore how 
technology- based approaches could capture patient- level 
data from patients with advanced cancer that has utility 
across the health system. Previous work by our team has 
highlighted the potential of digital health to facilitate 
the collection, sharing and use of patient- level data. For 
example, we know that mobile phones are frequently 
used in multiple ways as part of PC service provision in 
the African region and that development of approaches 
that capitalise on mobile phones is a high priority for 
providers.24 In SSA, mobile phone services are avail-
able to a larger portion of the population than many 
basic services (such as sanitation and financial services). 
Approaches using digital health can benefit from the 
widespread access and low cost of mobile phone devices 
in the region and have shown improved chronic disease 
management,24 patient behavioural change and health 
systems strengthening,25 reduced costs of patient moni-
toring, improved adherence and better communication. 
These benefits are greatest in rural areas.26 Furthermore, 
such patient to provider telemedicine has recently been 
recommended by the WHO as an approach that can 
support health systems strengthening.27
In recent years, there has been exploratory research 
and development of digital health approaches in PC 
services in SSA.28–30 However, this project seeks to address 
the lack of a theoretical underpinning to interventions 
using digital health components in this context. Our 
project will undertake engagement with key stakeholders 
(patient, caregivers, health professionals and policy- 
makers) across the health system to define the optimal 
mechanisms through which patient- level data, captured 
via digital health approaches, can be integrated into palli-
ative cancer care delivery and improvement.
RESEARCh oBjECTIvES And quESTIonS
The study aims to answer the question, what are the 
optimal mechanisms through which patient- level data, 
captured via digital health, can be used in the develop-
ment and delivery of palliative cancer care in SSA?
The specific objectives of the project are to:
1. Establish a consortium of academic researchers (from 
the UK, Nigeria, Uganda and Zimbabwe), service user 
advocates, non- governmental organisations, PC pro-
viders, policy- makers and digital health development 
and implementation experts to catalyse digital health 
research and generate evidence that can guide pallia-
tive cancer care development across SSA.
2. Understand the acceptability and optimal implemen-
tation of patient- level data collection (eg, PROMs and 
patient- reported experience measures) using digital 
health approaches in Uganda, Nigeria and Zimbabwe 
through patient and caregiver engagement.
3. Determine information needs and pathways for le-
veraging evidence generated from digital health ap-
proaches in service development in Uganda, Nigeria 
and Zimbabwe through health professional and ser-
vice manager engagement.
4. Determine information needs and pathways for le-
veraging evidence generated from digital health ap-
proaches in policy- making in Uganda, Nigeria and 
Zimbabwe through policy- maker engagement.
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5. Define the mechanisms for the implementation of dig-
ital health approaches to support development of pal-
liative cancer care in SSA.
6. Develop a theoretically informed logic model for im-
plementing digital health approaches to improve PC 
in SSA.
METhodS And AnAlySIS
Through partnership with the African Palliative Care 
Association (APCA), the University of Leeds have assessed 
the use and priorities of digital health approaches 
in PC services in the African region.28 Furthermore, 
King’s College London, working with APCA, have been 
pioneering patient- level data collection in PC in SSA 
and developing PROMs19 20; simple checklists of symp-
toms and concerns that are widely adopted and enable 
staff, patients and families to identify main concerns and 
prevent suffering, maintain people at home, support 
families and optimise function. PROMs for people with 
serious incurable illness can improve care and patient 
well- being. This project will enable integration of these 
research initiatives, determining the architecture of 
digital technologies to facilitate uptake and utilisation 
of evidence- based approaches such as PROMs. This will 
take forward the science of digital health in this neglected 
field, enabling a logic model to be developed for subse-
quent evaluation and implementation.
PC development in participating countries
The current development of PC for each participating 
country is summarised in table 1.
In recent years, policy reports of PC from participating 
study countries have commonly identified priority focus 
areas of improving access to pain medications, improving 
awareness by health professionals of the value and role of 
PC in supporting patients, and integration of PC with the 
existing public health system. A summary of policy docu-
ments and their key findings for each country is provided 
in online supplementary appendix A.
Study design
This study will adopt a multicountry, cross- sectional, 
exploratory study using qualitative methods. In- depth 
interviews with patients, caregivers, health professionals 
and policy- makers will be used to understand the accept-
ability and define mechanisms of patient- level data 
capture and usage. The interpretation of the findings will 
define optimal mechanisms through which patient- level 
data, captured via digital health, can be used in the devel-
opment, delivery and improvement of palliative cancer 
care in SSA. Alongside the planned research activities, a 
consortium focused on digital technology for palliative 
cancer care will be formed. This will include researchers 
from SSA and the UK, alongside key stakeholders in each 
of the participating countries (ie, relevant policy repre-
sentatives from ministries of health, civil society, patient 
advocates and digital health specialists) to understand: 
(1) current digital health development in Uganda, 
Nigeria and Zimbabwe; (2) opportunities for capacity 
development around digital health in palliative cancer 
care and (3) routes to uptake and translation of findings 
from planned research activities.
Study participants
The study participants will be adults living with advanced 
cancer, their caregivers, their health professionals and 
policy- makers with a focus on cancer, non- communicable 
diseases and/or technology. Patients will include adults 
with advanced cancer receiving PC. Caregivers will include 
those supporting palliative cancer patients receiving 
care from recruiting facilities. Health professionals will 
be drawn from the clinical teams associated with study 
partner institutes alongside related services delivered 
in the locality. Policy- makers will comprise district or 
national level policy- makers working within cancer, non- 
communicable diseases or digital health. Table 2 outlines 
the inclusion/exclusion criteria, sampling characteristics 
and sample size for the four stakeholder groups.
data collection and management
Patients
Clinical staff at recruiting facilities will be responsible for 
identifying participants. These staff will be asked to verify 
that patients are aware of their PC diagnosis. This will be 
through review of clinical records and discussion with the 
participant’s health professionals by the research assis-
tant. Patients who are deemed ethically inappropriate by 
members of the clinical team, for example, where death is 
imminent, will not be approached. Participating patients 
will only be asked to participate in one face- to- face inter-
view. The location of the interview will be decided by the 
patient or caregiver (ie, meeting either at their home, 
following a clinic appointment at a health facility, on the 
ward or at a neutral location, dependent on the patient’s 
preference and the patient’s clinical management at 
the time of the interview). Independent of the location 
chosen, a quiet and private room will be recommended to 
the patient for the interview. Arrangements will be made 
for such space at clinics and hospices ahead of interviews. 
A topic guide will be used to direct semistructured inter-
views with patients. The topic guide will explore current 
interaction with and access to PC services, their use of 
technology, the acceptability of using digital technology 
approaches to support interaction with health services 
and data collection, the clinical response anticipated 
from health services (with and without facilitation by 
digital health interventions) including perceptions of 
effective responses and alternative approaches to patient- 
level data collection without mobile phones.
Caregivers
Caregivers of patients with advanced cancer will be iden-
tified and approached to participate by clinical staff at 
recruiting facilities. Caregivers will only be required to 
participate in one face- to- face interview. A topic guide 
will be used to direct semistructured interviews with 
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Table 1 Summary of palliative care (PC) development in Nigeria, Uganda and Zimbabwe
Country Summary of development
Nigeria In Nigeria—the most populous country in SSA—PC is disparately spread in centres across the country. Historically, PC 
development in western Africa has been secondary to developments in the eastern and southern parts of the continent, and this 
continues to be the case. This is due mainly to the relatively low HIV prevalence, which meant that the region did not qualify to 
receive funding from the US President’s Emergency Plan for AIDS Relief (PEPFAR) in the early 2000s.32 Widespread interest in 
PC development in Nigeria emanated from the pain and suffering witnessed by concerned health professionals in patients with 
advanced cancer. Early efforts by the Hospice Nigeria team included an advocacy visit by Anne Merriman (the founder of Hospice 
Africa Uganda in 1993) which yielded little result as there was no opioid analgesics in the country to manage the associated 
cancer pain.33 The current movement that has resulted in establishment of holistic PC services across Nigeria commenced in 
1996 with the Ibadan ‘Cancer pain group’.34 Concerted advocacy and other activities of the group facilitated importation of opioid 
analgesics by the Federal Ministry of Health for the management of severe pain by 2001 and morphine powder for oral morphine 
preparation by 2005.
The first PC team was founded in 2003 at Ibadan, providing both hospital- based and home- based services,32 and the Hospice 
and PC Association of Nigeria was created in 2007. Members, most of whom received PC initiator’s training at Hospice Africa, 
Uganda, function as individuals or teams across the six geopolitical areas of the country. Home- based PC continues as a very 
important form of PC delivery, with evidence of its benefits to patients and their families.35 Some aspects of PC are now included 
in the national guidelines for HIV and AIDS treatment and care in adolescents and adults (2012) as well as the national cancer 
control plan of the Federal Ministry of Health (2018–2022).
Current barriers to PC development include lack of government guidelines, poor knowledge about PC importance at all levels—
policy- makers, public, health professionals, lack of inclusion of PC in curricula of health professionals and in the national health 
budget and National Health Insurance Scheme, poor availability and accessibility of strong opioid analgesics for cancer pain 
management. However, since 2012, the ‘Treat Pain project’ and ‘Pain Free Hospital Initiative’ of the Federal Ministry of Health, 
Global Access to Pain Relief Initiative and American Cancer Society have improved the opioid situation.36 37 More can still be 
achieved through the training of more health professionals and change of attitude, increased funding and increased public 
awareness of the services.35 There has been some early context setting work suggesting willingness to explore the application of 
technology within PC services, such as the use of telemedicine.38
Uganda The Atlas of Palliative Care Development in Africa ranked Uganda highly in terms of palliative service development and its 
integration into the health system.39 Prior to this, The Economist Intelligence Unit’s Quality of Death Index40 which is a ‘measure 
of the quality of PC provided to adults in over 80 countries’, ranked Uganda as 35th in the world. This index gives a general 
impression of the quality of life at the end of life and recognises continued development of PC services in Uganda. In terms for 
service delivery, Uganda has over 229 PC service outlets, for a population of 40 million people. These include hospices, home- 
based care and health facility- based outlets. The level of paediatric PC service development remains poor, with two paediatric PC 
service centres despite a large population of children and young people.1
In terms of the wider health system, Uganda has been progressing the presence and development of PC services. Uganda 
is building a critical mass for PC professionals with PC integrated into the medical and nursing and is a hub for training and 
education in PC, with diploma, certificate and degree courses in PC provided by universities, specialised PC institutions like 
Mildmay Uganda, and international organisations like African Palliative Care Association (APCA). In terms of health information 
systems, there are two national indicators of PC into the national electronic health information system: patients presenting with 
pain and those receiving morphine for pain management. With this advancement, to some extent, performance of PC can be 
monitored at the national level.
Access to pain medication is a crucial component of PC delivery in Uganda. The availability of the full analgesic ladder and 
palliative medicines remains poor,41 compromising care providers’ ability to support management of symptoms and alleviate 
suffering associated with pain. However, Uganda has introduced prescribing across cadres other than doctors, such as PC nurse 
prescribers. Furthermore, the rolling out of local production of morphine within Hospice Africa Uganda led to significant reductions 
in costs associated with morphine procurement.42 This key opioid for moderate to severe pain is now provided free of charge and 
is supplied through the national supply chain mechanisms of the country. Although oral morphine is free, access still remains a 
challenge because of several factors such frequent stock outs, reluctance to prescribe morphine for fear of addictions as well as 
limited access to this medicine at primary healthcare level.29
PC is included in the national health strategic plan, and in the HIV care guidelines. A stand- alone PC policy was drafted in 2017 
and is pending cabinet approval. It is envisioned that a stand- alone policy will be a strong pillar in giving a strategic direction to 
service development and evaluation to provide a comprehensive framework for the integration of PC services into the healthcare 
system. It will also be used as tool to advance financing for PC advocacy.
Continued
H
ospital M
edical Library. Protected by copyright.
 o
n
 N
ovem
ber 2, 2019 at Assistant Librarian St Jam
es`s
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032166 on 31 October 2019. Downloaded from 
5Okunade K, et al. BMJ Open 2019;9:e032166. doi:10.1136/bmjopen-2019-032166
Open access
Country Summary of development
Zimbabwe In 2014, a WHO report identified 1 in 60 Zimbabweans need PC,43 alongside an International Children’s Palliative Care Network 
report identifying a significant need among children across multiple provinces in Zimbabwe.44 Despite the continuing high level 
of PC need, Zimbabwe was the first country in sub- Saharan Africa to have a hospice, founded in 1979. In terms of development 
of PC across the country, by 1997 there were 17 regional branches that had been formed throughout the country with 13 
organisations providing PC by 2004.45 The disease focus of PC in Zimbabwe was initially cancer, although the growth of the 
disease burden due to HIV and AIDS led to widening of provision to include those living with HIV and AIDS and other chronic 
illnesses. Notable initiatives have facilitated PC services provision in the country. In 1992, the Ministry of Health and Child Care 
formed the Prevention and Control of Cancer Committee in Zimbabwe that comprised relevant stakeholders and professionals. 
The committee oversaw the development of a 10- year National Cancer Control Programme Plan for Zimbabwe (1994–2004), with 
the overall aim to formulate, plan and implement a coordinated and cost- effective programme for the prevention and control of 
cancer in Zimbabwe. This led to the establishment of PC training across eight provinces and two cities of Harare and Bulawayo. 
The APCA in 2010 reviewed national policy documents and implementation guidelines from 10 Southern African countries, 
including Zimbabwe.46 For Zimbabwe, while PC was highlighted as a priority area across documents, issues around minimal 
coverage of PC was noted alongside an absence of detail relating to opioid availability. In more recent years, the Worldwide 
Hospice Palliative Care Association global update of mapping levels of PC provision in 2014 placed Zimbabwe in category 4a.47 
Category 4a suggests a country as hospice- PC services at a stage of preliminary integration into mainstream service provision. 
This category suggests the development of a critical mass of PC activism in a number of locations, a variety of PC providers and 
types of services, awareness of PC on the part of health professionals and local communities, the availability of morphine and 
some other strong pain- relieving medicines, limited impact of palliative care on policy, the provision of a substantial number of 
training and education initiatives by a range of organisations, and interest in the concept of a national PC association.
Table 1 Continued
caregivers. The themes addressed in the topic guide will 
align with the patient topic guide.
Healthcare professionals
Health professionals will be identified by clinical leads in 
each of the three countries. Through existing networks 
of PC providers in each of the countries, the clinical lead 
will approach health professionals to participate in the 
study. A topic guide will be used during health profes-
sional interviews. The topic guide aligns with stages of 
the data- use conceptual framework15: data demand (eg, 
current availability, use and quality of data for clinical 
decision- making), data collection (eg, feasibility of digital 
technology approaches to patient- level data collection), 
data availability (eg, clinical triggers in management of 
patients with advanced cancer, capacity to respond to infor-
mation, information needs to inform patient care) and 
data utilisation (eg, sharing and accessing data via digital 
health approaches, data reporting priorities to regional 
and national health authorities). Causal elements linked 
to organisational, technical and behavioural factors influ-
encing data use will be explored for each stage.
Policy-makers
Policy- makers will be identified and approached by the 
APCA alongside academic and clinical teams in Nigeria, 
Uganda and Zimbabwe. A topic guide for key informant 
interviews will address access to and use of evidence to 
inform decision- making, seek comment on findings 
from a desktop review of existing policy on digital health 
to be conducted prior to key informant interviews, 
preferred mode and presentation of data, frequency of 
data reporting needed to inform decision- making on 
financing of PC services and on accelerating UHC.
Interviews across all recruitment sites in Uganda, 
Nigeria and Zimbabwe (outlined in online supple-
mentary appendix B) will be undertaken by research 
assistants, supervised by the academic partners in Nigeria 
(KO), Uganda (ENamu) and Zimbabwe (MC). All inter-
views will be audio- recorded. Data security will be ensured 
through use of password- protected file sharing using the 
Microsoft OneDrive platform. Separate folders will be 
created for each country, with oversight from the lead 
institution, the University of Leeds. Only research team 
members will have access to the folder. All members of the 
project team will sign a data sharing agreement outlining 
explicit guidance regarding handling and management 
of research data that takes account of both the funders 
and national research council guidelines. On completion 
of this study, all electronic data on the OneDrive folder 
will be moved to an electronic archive for 5 years prior to 
being permanently destroyed. Deidentified research data 
deemed suitable for sharing will be hosted by Research 
Data Leeds, the institutional research data repository 
for the University of Leeds. All study participants will be 
assigned an identification code, which will be delinked 
from their identity at data entry point.
Reflectivity
The research team comprises experts in digital health 
intervention development (MJA, BE), qualitative research 
(DA, AD, ENamu), global PC provision (KBN, ENami, EL, 
RH), monitoring and evaluation (LM), health services 
research in SSA (MC) alongside consultants in palliative 
medicine (ENamu, HD, OS, MIB) and oncologists (KO, 
OS). None of these researchers have any relationship 
with the patients or caregivers who will be approached to 
participate. However, a small number of the healthcare 
professionals or policy- maker participants may be known 
contacts.
Patient and public involvement
The rationale for this work arose from priorities iden-
tified through surveying a key stakeholder group, 
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Table 2 Population and sampling criteria for the four stakeholder groups
Participant 
group Eligibility criteria Sampling criteria
Target number 
to recruit in each 
participating country
Patient Inclusion criteria:
 ► Patients with advanced cancer (defined as those with 
metastatic cancer (where, if possible, determined 
through histological, cytological or radiological 
evidence) and/or those receiving anticancer therapy 
with palliative intent receiving palliative care
 ► Aged ≥18 years
Exclusion criteria:
 ► Patients with significant cognitive impairment that 
prevents informed consent
 ► Inadequate physical and mental health of a patient 
prior to recruiting (as deemed by the identifying 
clinician)
 ► Lack of a shared language between researcher and 
respondent
 ► Below 18 years of age
 ► Age
 ► Sex
 ► Cancer type
 ► Location at the time of 
interview (community 
based or ward based)
 ► 20 purposely 
selected patients
Caregiver Inclusion criteria:
 ► A primary caregiver/family caregiver of a patient with 
advanced cancer who is at least 18 years of age
 ► Primary caregiver confirmed by the patient, including 
those who provide unpaid, informal provision of one or 
more physical, social, practical and emotional tasks. 
In terms of their relationship to the patient, they may 
be a friend, partner, ex- partner, sibling, parent, child or 
other blood or non- blood relative
 ► Both caregivers of participating and non- participating 
patients will be recruited into the study
Exclusion criteria:
 ► Below 18 years of age
 ► Inadequate physical and mental health of a patient 
prior to recruiting (as deemed by the identifying 
clinician)
 ► Sex
 ► Age
 ► Patient involvement 
in study (ensuring 
representation of those 
where the patient 
whom they care for has 
participated, and those 
where the patient has not 
participated)
 ► 15 purposely 
selected caregivers
Health 
professional
Inclusion criteria:
 ► Working with palliative care patients
 ► At least 6 months working experience at recognised 
palliative care facilities
 ► Role (doctor, clinical 
officer, nurse, social 
worker, psychologist, 
pharmacist)
 ► Typical work setting (ie, 
community based, ward 
based)
 ► 20 purposely 
selected health 
professionals
Policy- 
maker
Inclusion criteria:
 ► Representative from government ministry or national 
association responsible for oversight and development 
of healthcare in participating country
 ► Working at different levels 
of the health system 
(district, national)
 ► Policy remit of their 
post (cancer, non- 
communicable diseases, 
digital health)
 ► Up to 10 
purposely selected 
policy- makers
healthcare providers delivering PC across SSA.24 Patients 
and caregivers were not involved in the design of the 
study. However, alongside research activities, the team 
will develop a consortium which will include patient 
advocates. This forum will be used to explore routes for 
communicating study findings to patient groups and help 
to establish potential routes for identifying patient and 
caregivers, or advocates, in subsequent projects.
Study dates
November 2018–December 2019. Policy- maker engage-
ment will begin in November 2018, with data collection 
commencing in March 2019.
data analysis
Interviews will be transcribed verbatim and translated 
into English before being imported into NVivo software 
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for deductive framework analysis.31 An initial charting 
of pseudonymised transcripts (KBN) will be developed 
through line- by- line coding. This initial code will then be 
applied to a random set of transcripts (n=3) in each stake-
holder group by three further members of the research 
team (Nigeria, Uganda, Zimbabwe), and the final frame-
work agreed through discussion with the wider team. 
Once inconsistencies are resolved, the joint coding frame 
will be used to code all interviews across the participant 
group. Comparative analysis in the framework will enable 
us to identify common themes as well as country- specific 
and stakeholder group divergences. A model of the coding 
frame will be developed, and each theme and subtheme 
given a definition to ensure internal consistency of each 
code. Illustrative codes will be reported for each theme, 
with the study ID code to demonstrate reporting from 
across the sample breadth. In the final project meeting 
we will hold a Theory of Change workshop to model 
the planned digital health pathway within its context, 
detailing processes, stakeholder roles, outcomes and 
intended impact.
Ethical considerations
Ethics approvals have been obtained from the Insti-
tutional Review Boards of University of Leeds (Ref: 
MREC 18–032), Research Council of Zimbabwe (Ref: 
03507), Medical Research Council of Zimbabwe (Ref: 
MRCZ/A/2421), Uganda Cancer Institute (Ref: 
19–2018), Uganda National Council of Science and Tech-
nology (Ref: HS325ES) and College of Medicine Univer-
sity of Lagos (Ref: HREC/15/04/2015). Ethical review 
undertaken by all project investigators ensured stan-
dard processes (dignity, autonomy, informed consent, 
confidentiality, anonymity, ability to adhere to protocol) 
and data security were considered in the protocol devel-
opment. The project will be aligned with the Medical 
Research Council good research practice guidelines and 
H3Africa framework for conducting ethically responsible 
biomedical research. With reference to research on PC 
populations, a patient’s condition should not preclude 
them from participation. Instead, additional strategies of 
harm minimisation have been developed collaboratively 
by the research team. Academic leads and coinvestigators 
will support protocol adaptation for local cultural appro-
priateness (eg, modifying recruitment accounting for 
cancer- related stigma). Researchers will routinely contact 
clinical teams to check the health status of a patient 
prior to contact for research activities. In terms of data 
governance, project documentation and deidentified 
data for joint analysis will be shared via a secure IT infra-
structure hosted by the University of Leeds. Voluntary 
and informed participation, confidentiality and safety of 
participants will constitute key principles of researcher–
respondent interaction. Written consent or a thumb print 
will be obtained from patients, caregivers, healthcare 
professionals and policy- makers prior to their enrolment 
in the study.
dissemination
We will provide an understanding of the mechanisms by 
which digital health approaches can facilitate evidence 
generation and use, ensuring optimal implementation 
with clear pathways for integrating captured data into 
existing health system functions. On completion of 
planned research activities, we will have:
1. Instigated an active, interdisciplinary consortium fo-
cused on technology- based approaches to developing 
palliative cancer care in SSA.
2. Defined mechanisms for optimal implementation of 
digital health interventions to support PC service de-
velopment in SSA.
3. Provided a list of factors to target with digital health 
approaches with accompanying programme theory.
4. Obtained essential preliminary data needed to inform 
future research in digital health technology develop-
ment for PC in SSA.
5. Developed a logic model for implementation of digital 
health to improve advanced cancer care in SSA.
6. Strengthened capacity for research, innovation and 
knowledge exchange in partner institutions and iden-
tified future capacity building needs.
Undertaking primary research with patients, caregivers, 
health professionals and policy- makers is essential to 
guide digital health approaches for palliative cancer 
care in SSA. A number of activities will be undertaking 
to support dissemination of project findings. These will 
include: (1) developing newsletters and press releases to 
communicate key project findings to the general public, 
(2) developing a dedicated website for the study where 
results will be publicly accessible by national and inter-
national policy- makers, practitioners and academics, (3) 
delivering presentations at local and national confer-
ences in participating countries, alongside presentation 
at international conferences, (4) publishing articles in 
peer- reviewed journals and (5) social media through 
research team member and institutional accounts. Partic-
ipants will be anonymised in any dissemination activities. 
Only pseudonymised, non- identifiable characteristics and 
quotes will be used in dissemination.
ConCluSIon
This paper reports the protocol for a cross- sectional study 
with qualitative methods aimed at understanding the 
optimal mechanisms through which patient- level data, 
captured via digital health, can be used in the devel-
opment, access and delivery of quality palliative cancer 
care in Uganda, Nigeria and Zimbabwe. The findings of 
the study will be device agnostic, providing a theoretical 
framework that can be used to inform a wide range of 
digital health intervention development and implemen-
tation. Without this research there is a risk of digital 
health intervention development for PC occurring in 
silos across SSA that do not take account of the multiple 
uses and value of data for stakeholders across the wider 
health system. Mapping information and data needs 
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across PC services will also create multiple opportunities 
for research. This includes subsequent piloting and evalu-
ation of digital health interventions and validation of the 
data they capture, development of patient- focused digital 
health interventions such as information provision and 
self- management support, and exploration of the influ-
ence of factors such as gender, intersectionality, disability 
and cancer type on utilisation and engagement with digital 
health approaches. Subsequent development of digital 
health approaches for PC in SSA, gathering patient- level 
data and facilitating patient- provider communication, 
could lead to multiple benefits for patients and caregivers 
(reduced costs associated with time and travel to facilities, 
extend coverage and reach of services such as rural areas 
with mobile connectivity), health professionals (ability 
to identify and respond to specific and rising demand 
from patients with cancer) and policy- makers (receiving 
appropriate and timely data to inform service planning, 
guide integration of PC with wider healthcare delivery 
and contribute to strengthening of national digital health 
systems). There is an added imperative to understand how 
best to use digital health technologies for those receiving 
and providing care for advanced disease in SSA. There is 
currently a lack of evidence on the preferences of patients 
with advanced disease, their caregivers and their health 
professionals. Understanding these preferences is crucial 
to inform digital health intervention development, such 
as modelling interventions around the preferences of the 
timing and delivery of digital health approaches in PC.
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